insights_auto
Why is 8NE down 5,47%?
Dive Deeperchevron_right
8NE:FRA
Lisata Therapeutics, Inc.
€1,21
arrow_downward
-5,47%(-0,070) 1D
2 Okt., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 8NE...
Open
€1,20
High
€1,21
Low
€1,20
Mkt. cap
15,88 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€4,34
52-wk low
€0,74
No. of employees
21
Open
€1,20
High
€1,21
Low
€1,20
Mkt. cap
15,88 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€4,34
52-wk low
€0,74
No. of employees
21
News stories
From web sources and news partners
Yahoo! Finance Canada
·
2 minute gelede
AMN,HLF,BSBK,FXNC,IMRX,CRMT,MRBK,ORN,TISI,FRST,GRNT,VSTS,GEF-B,RVSB,SHEN,DCGO,TMCI,SABR,BCRX,NBBK,USCB | Stock Prices | Quote Comparison
Simply Wall Street
·
18 minute gelede
Here's Why We're Not At All Concerned With Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation
Seeking Alpha
·
1 uur gelede
My Biggest Warning For Anyone Who Owns The S&P 500 (NYSEARCA:SPY)
The Motley Fool
·
3 uur gelede
The S&P 500 Hasn't Looked This Cheap Based on a Popular Metric in Decades. Should You Buy Stocks Now?
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics, Inc.
CEO-
Employees21
Founded1980
HeadquartersBasking Ridge, New Jersey, Verenigde State van Amerika
Sector-
Websitelisata.com